Axonics Inc (AXNX) Company Profile & Statistics

Axonics Inc
AXNX
(Nasdaq - US)
Open
70.98
+0.53 (+0.75%)
in:usd•As of: Nov 14, 2024 15:59 UTC -5
Open
70.45
High
71.04
Low
70.37

About Axonics Inc

CEO

Raymond W. Cohen

Headquarters

26 technology drive

irvine, ca 92618, united states

Auditor

BDO USA, P.C.

Employees

797

Share Holders

715

Website

www.axonics.com

Industry

medical specialties

Sector

health technology

Company Overview

Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA.

Axonics Inc Statistics

Valuation Measures

Market Capitalization ²	3.63B
Enterprise Value	3.39B
Enterprise Value/EBITDA (ttm)	-412.71
Price to Earnings Ratio (ttm)	1.77K
Price to Book (mrq)	5.46
Price to Sales (ttm)	8.40
Price to Cash (ytd)	561.96

Profitability

Gross Margin (ttm)	76.54%
Operating Margin (ttm)	0.54%
Profit Margin (ttm)	-2.23%
Return on Equity (ttm)	0.36%
Return on Invested Capital (ttm)	-0.95%
Return on Assets (ttm)	0.31%

Income Statement

Revenue (ttm)	431.90M
Revenue Per Share (ttm)	8.45
Gross Profit (ttm)	330.81M
EBITDA (ttm)³	-8.21M
Net Income Avi to Common (ttm)	-5.66M
Diluted EPS (ttm)	-0.12

Share Statistics

Beta (5Y Monthly)	0.82
52-Week Change	23.12%
S&P500 52-Week Change	29.72%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	51.11M
Dividend Yield	0.00%
Float ⁴	50.16M
% Held by Insiders	1.85%
% Held by Institutions	99.48%

Balance Sheet

Total Cash (mrq)	345.23M
Total Cash Per Share (mrq)	6.75
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	8.16%
Quick Ratio (mrq)	6.40%
Book Value Per Share (mrq)	13.00

Cash Flow

Operating Cash Flow Per Share (ytd)	0.17
Free Cash Flow (ytd)	1.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Axonics Inc

Trade With A Regulated Broker